MyDawa: valuation, funding rounds and share price

None of the 1 round we track for MyDawa disclosed a valuation, so the company's valuation is not disclosed.

MyDawa has raised $9.6M across 1 disclosed round tracked by Africa Markets. Valuations are as reported at announcement and may not reflect current value.

No. MyDawa is a private company and its shares are not listed on a stock exchange, so there is no public MyDawa stock price. No valuation has been disclosed in the rounds we track.

MyDawa also appears as MYDA in the Africa Markets trading demonstration, a members-only preview of our marketplace. Prices there come from a demonstration call auction in which members trade with demo cash; they are not real market prices, not a valuation of MyDawa, and no real shares change hands. Members can view MYDA in the demonstration.

MyDawa operates a bricks-and-clicks model combining an e-commerce platform for medicines, health and wellness products with a growing network of physical pharmacies. It provides online doctor consultations, e-prescriptions, laboratory testing, chronic disease management programs and medication delivery. The company serves patients directly in Kenya and Uganda, where it expanded via the 2023 acquisition of Guardian Health (pharmacy chain) and later Rocket Health (telehealth provider). It has also acquired The Medical Concierge Group.

The business model integrates digital tools (including AI for inventory and service optimization) with physical infrastructure to reduce costs in the fragmented pharmaceutical supply chain, improve access to quality medication and professional care, and support chronic care for thousands of patients. In 2024 it reported serving over 1.8 million patients and enrolling more than 5,000 in chronic-disease programs. It aims to scale further across East Africa.